If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
The Series B shares reported herein includes 25,263,873 Series BB shares convertible into Series B shares. The calculation of the percentage set forth in row 13 above is based on an aggregate 519,226,576 Series B shares outstanding as of May 7, 2026 as disclosed by the Issuer on Form 6-K filed with the Securities and Exchange Commission ("SEC") on May 7, 2026, and assumes the conversion of the Series BB shares held by the Reporting Person (as defined below).


SCHEDULE 13D


 
Laura Diez-Barroso Azcarraga
 
Signature:/s/ Laura Diez-Barroso Azcarraga
Name/Title:Laura Diez-Barroso Azcarraga
Date:05/13/2026

ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

AN ENGLISH TRANSLATION OF THE MERGER AGREEMENT, DATED AS OF APRIL 30, 2026